Skip to main content
. Author manuscript; available in PMC: 2021 Sep 22.
Published in final edited form as: Vaccine. 2020 Aug 20;38(41):6357–6362. doi: 10.1016/j.vaccine.2020.08.023

Figure 2. Alum-adjuvanted RSV PreF vaccination elicits a type-2 innate immune response.

Figure 2.

Mice were challenged, immunized, and re-challenged with RSV as described in Figure 1. At 4dpi, BAL was harvested for quantification of eosinophils (A), neutrophils (B), and monocytes (C). Lungs were harvested and homogenized for quantification of ILC2s (D) and ILC2 intracellular cytokine staining of IL-5 (E) and IL-13 (F). Data are represented as mean ± SEM. Statistical significance between vaccination groups was calculated using one-way ANOVA with Tukey’s multiple comparison post-test between all groups. **p<0.01, ***p<0.001, and ****p<0.0001.

HHS Vulnerability Disclosure